Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: joemjo who wrote (619)	12/5/1997 5:52:00 PM
From: Frank Buck	Read Replies (1) \| Respond to of 1894

Todd, I believe you make some excellent points. That is that the hot money (the-party-is-over-crowd) has left . They took with them some of the other guests that were nervous about the previous two quarter numbers. I believe that some will be back, others might wish they had come back, others will never look back. The selling into a vacuum statement may or may not be long-lived depending on the other "treats" we have been told to expect. Hopefully this will be a quarter where AccuMed will "exceed" analysts expectations by 99%. It could happen if the large orders for molecularbiology panels are substantial, if the Leica-international sales team has been well received abroad and if domestically the decision making boards have adjourned and given the OK to purchase. The last statement you make concerns me. That is..."I do not understand their products from a user point of view." I can understand if you said I don't have a working knowledge of cells or bacteria or reactants/broth or something like that. The sole purpose of this company is not locked in some mysterious proprietary machine, patents or combination of dry-powders. It is simply using available resources, microscopes, computers, hand-held mice, plastic panels with chemicals inside in a way that hasn't been done before. That is what technology is about. Making "better" use of existing resources. The combining of these resources (after studying the "WAY" that they have been done in the past) is what makes AccuMed different. They are enhancing the detection of abnormalities. That is it. Other companies like CYTC, NPTH, CVSN etc. also package, bundle and attempt to market "their-perception" of what they deem to be a better way at facilitating OR automating (completely removing the human element) from the detection of abnormalities. None of the companies as far as I know have any products beyond the evaluation/enhancing level. None of them has a cure for an abberrantly multiplying cell or tissue. Basically everything needed to understand the products of all the companies is available to the reader via their SEC postings if you care to r-e-a-d and r-e-a-d and r-e-a-d. You on the other hand it sounds like do better at interpretting the numbers from a fundamental basis. Sometimes I think that is more difficult to understand than learning the products/services of a company. Neither should be more difficult than the other if the proper amount of time and effort is put into it. That's what makes these threads/forums/message-posting places so great. We as investors have an opportunity to learn from one another. My weak point might be your strong point. Wonderful! A long way from years ago when your broker called you and recommended a particular equity because they the (brokerage-house) was pushing it. Half the time we never saw any info until shareholder reports came out. We just used the little S&P monthly "bible" and our guts. Today-WOW! Instantaneous information overload. Jump in a forum and talk to other shareholders or perspective shareholders. I might miss some element that Ryan, George etc. doesn't miss. I might dig here and find this or that. George was able to go to the convention and share the info. Ten heads are better than one. I wonder how many non-subscribers are out there wishing they could join in. Hopefully they won't leave a few individuals do all the digging and writing. Keep up the great postings guys. I think we are doing well at figuring out this sector as a whole. Anyway I am sounding like I am running for office or something. I wonder if the Company has indeed hired a new PR firm. Has anyone checked the AccuMed Website lately? Later.